Left common trunkus pulmonary veins have genetic background and poor rhythm outcome after atrial fibrillation catheter ablation

نویسندگان

چکیده

Abstract Funding Acknowledgements Type of funding sources: None. Background There is a genetic background in pulmonary vein (PV) development and atrial fibrillation (AF). However, the trait PV variations their rhythm outcome after AF catheter ablation (AFCA) unclear. Objective We explored clinical characteristics long-term outcomes patients with variation or left common trunkus (LCT)-PV. Methods included 2,897 (74.0% male, age 59.0 ± 10.7 years, 66.3% paroxysmal AF) available genome-wide association study results, cardiac computed tomogram data, protocol-based regular follow-up from Yonsei cohort database. defined LCT-PV when upper lower separate at >10 mm distal to antrum margin. both accessory PVs. analyzed polygenic risk score (PRS) 12 AF-associated genes (DSP, GJA1, HCN4, KCNQ1, NPPA, PITX2, RYR2, SCN5a, SHOX2, ATP2A2, TBX3, TBX5) AFCA. Results found 296 (10.2%) 102 (3.5%). PRS 1,227 single nucleotid polymorphisms (SNPs) was significantly higher (p=4.93e-08) (p=1.95e-20). The had CHA2DS2VASc scores (p=0.024) epicardial adipose tissue volume (p=0.034). During 39.7 34.8 months period, recurrence rate than counter part sub-group (Log-rank p=0.036), but not overall variations. highest 10% independently associated AFCA (HR 2.10, 95% CI 1.21-3.63, p=0.008). Conclusions Among who underwent AFCA, variation, including LCT-PV, has significant background. post-AFCA high PRS, especially AF.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Pulmonary veins: preferred site for catheter ablation of atrial fibrillation.

Atrial fibrillation (AF) is one of the most challenging arrhythmias to treat. Many patients have to accept this disorder and the medications required. Nonpharmacologic therapies have emerged as alternative methods of treatment. However, technical difficulty, low success rate, high recurrence, and complications still are obstacles. Pulmonary veins as the most common trigger foci of paroxysmal AF...

متن کامل

Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation.

BACKGROUND Segmental ostial catheter ablation (SOCA) to isolate the pulmonary veins (PVs) and left atrial catheter ablation (LACA) to encircle the PVs both may eliminate paroxysmal atrial fibrillation (PAF). The relative efficacy of these 2 techniques has not been directly compared. METHODS AND RESULTS Of 80 consecutive patients with symptomatic PAF (age, 52+/-10 years), 40 patients underwent...

متن کامل

Long-term outcome after successful catheter ablation of atrial fibrillation.

BACKGROUND Pulmonary vein isolation (PVI) is increasingly used for treatment of atrial fibrillation (AF), but few reports exist regarding long-term success. We determined 5-year outcomes of PVI among patients with freedom from AF off antiarrhythmic drugs (AAD) for 1 year after PVI. METHODS AND RESULTS Consecutive patients with paroxysmal or persistent AF who underwent PVI at the University of...

متن کامل

Pulmonary Vein Stenosis After Catheter Ablation of Atrial Fibrillation

Catheter ablation around the pulmonary veins (PVs) has become the treatment of choice for symptomatic patients with atrial fibrillation (AF) who do not respond to pharmacological therapy [1–6]. Over the past few years, a variety of strategies have been developed to achieve cure of AF [7–16]. PV stenosis is a known potential complication of radiofrequency ablation (RF) around the PVs [17–24] and...

متن کامل

Pulmonary vein stenosis after catheter ablation for atrial fibrillation.

Tree randomized trials (PIAF, AFFIRM, and RACE)1-3 recently showed that rate control was not inferior compared to rhythm control for treatment of patients with atrial fibrillation (AF). However, it should be noted that frequent recurrences of AF and adverse effects of drugs decrease the potential benefits of rhythm control, prompting discontinuation of failed drugs in up to 40% of patients.2 In...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Europace

سال: 2023

ISSN: ['1099-5129', '1532-2092']

DOI: https://doi.org/10.1093/europace/euad122.175